BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Nov. 14, 2007
View Archived Issues
Antisense Pharma Gets $39.5M For Antisense Glioma Product
Antisense Pharma GmbH raised €27 million (US$39.5 million) in a third investment round funded solely by MIG AG, which also was the only investor in its €18 million funding round two years ago. (BioWorld International)
Read More
Acambis Partners West Nile Vaccine In $80M Sanofi Deal
Read More
Novel Obesity Gene Plays A Role In Modifying DNA
Read More
Actelion Advances Clazosentan Into Phase III Vasospasm Study
Read More
Peptech Reinvents Itself As Arana, Shifts To Antibodies
Read More
Cerep Sells Hesperion To CRO Averion In €25M Deal
No Abstract
Read More
Activists Strike At European Industry's Lobbying Power
Read More
Other News To Note
Read More
LSD Deal Brings Amicus $50M Now, $390M Later
Read More
As Big Pharma Model Falters, Biotech Rides To The Rescue
Read More